{
  "id": 442348,
  "title": "Starbucks ends employee coverage for these medicines amid rising US health costs",
  "url": "https://urgent.news/2026/08/10/starbucks-ends-employee-coverage-for-these-medicines-amid-rising-us",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-10T02:59:48.000Z",
  "source": {
    "name": "Times of India",
    "slug": "times-of-india",
    "url": "https://timesofindia.indiatimes.com/technology/tech-news/as-companies-in-america-face-rising-health-costs-starbucks-ends-employee-benefits-coverage-for-these-medicines/articleshow/133078802.cms"
  },
  "original_language": "en",
  "account": null,
  "summary": "Starbucks will cease covering GLP-1 weight-loss drugs for employees starting October. This decision reflects rising costs and a broader employer trend in benefits. GLP-1 drugs, initially for diabetes, are now popular for obesity treatment. Other companies like Allina Health and PwC have also adjusted their coverage policies. However, Bank of America views GLP-1 coverage as a vital employee health…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}